Paula J. Swain - Jan 1, 2022 Form 4 Insider Report for INCYTE CORP (INCY)

Signature
/s/ Paula Swain
Stock symbol
INCY
Transactions as of
Jan 1, 2022
Transactions value $
-$2,330
Form type
4
Date filed
1/5/2022, 03:25 PM
Previous filing
Nov 23, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Award $0 +8.68K +13.62% $0.00 72.4K Jan 1, 2022 Direct F1
transaction INCY Common Stock Options Exercise $682K +9.32K +12.88% $73.21 81.7K Jan 4, 2022 Direct F2
transaction INCY Common Stock Sale -$685K -9.32K -11.41% $73.46 72.4K Jan 4, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Non Qualfied Stock Option (right to buy) Options Exercise $0 -9.32K -46.16% $0.00 10.9K Jan 4, 2022 Common Stock 9.32K $73.21 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Paula Swain's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
F3 Represents weighted average sale price. Actual sale prices ranged from $73.31 - $73.73. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of shares sold within range indicated.
F4 Includes an aggregate of 33,663 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F5 Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.